Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension.

Chaouat, A; Coulet, F; Favre, C; Simonneau, G; Weitzenblum, E; Soubrier, F; Humbert, M · Thorax · 2004

case_report · Level V

Where this comes from

Abstract

Dexfenfluramine associated pulmonary arterial hypertension occurring in a patient with hereditary haemorrhagic telangiectasia related to a mutation within the endoglin gene is described. This report highlights the critical role of the TGF-beta signalling pathway in this condition.

Medical subject headings